1. Shulgin A, Nichols D. Characterization of three new psychomimetics. In: Stillmann R, Wilette R, editors. The Psychopharmacology of Halluzinogens. New York: Pergamon; 1978. pp. 74–82.
2. Shulgin A. Pihkal: a chemical love story. Berkeley: Transform Press; 1995.
3. State RC, Grob CS, Poland RE, editors. Psychobiologic Effects of 3,4-Methylenedioxymethamphetamine in Humans: A Pilot Study (Poster). MDMA/Ecstasy Research: Advances, Challenges and Future Directions; 2001; Bethesda, MD: US Goverment.
4. Liechti ME, Geyer MA, Hell ID, Vollenweider FX. Effects of MDMA (Ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin. Neuropsychopharmacology. 2001;24:240–252.
5. Liester MB, Grob CS, Bravo GL, Walsh RN. Phenomenology and sequelae of 3,4-methylenedioxy-methamphetamine use. J Nerv Ment Dis. 1992;180:345–352.